UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT
TO SECTION 14(a) OF THE
SECURITIES EXCHANGE
ACT OF 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement |
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ |
Definitive Proxy Statement |
| ☐ |
Definitive Additional Materials |
| ☒ |
Soliciting Material Pursuant to § 240.14a-12 |
CROSS COUNTRY HEALTHCARE,
INC.
(Name of Registrant
as Specified In Its Charter)
(Name of Person(s)
Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that
apply):
| ☐ |
Fee paid previously with preliminary materials. |
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
The following email and FAQs were sent
by John A. Martins, President and Chief Executive Officer of Cross Country Healthcare, Inc. (“Cross Country”), to
employees of Cross Country on December 4, 2024 in connection with the proposed acquisition of Cross Country by Aya Healthcare,
Inc.
Dear Cross Country Team,
We are thrilled to share some exciting
news. This morning, we announced that we have entered into an agreement for Cross Country to be acquired by Aya Healthcare. You can read
the press release on the Investor Relations page of our website at https://ir.crosscountryhealthcare.com/press-releases.
As many of you know, Aya is a leading
healthcare talent software and staffing company based in San Diego. The clinical services we provide in clinical and non-clinical settings,
including in schools and homes, as well as our IntellifyTM workforce platform will complement Aya’s existing capabilities.
Together, we will be able to offer customers tech-enabled workforce solutions across the continuum of care, reduce costs and deliver
high clinical outcomes for patients. Importantly, we expect the transaction to provide a wider array of opportunities and efficiencies
for our healthcare clinicians and create new opportunities for our employees as part of an industry leader with a complementary footprint
and offering.
Aya shares our commitment to the core
values that drive how we conduct our business, treat our employees and serve our customers, and this same focus will guide our actions
as we combine our two companies.
In terms of next steps, we expect the
transaction to close in the first half of 2025, subject to the approval of Cross Country stockholders and other customary closing conditions.
Until then, we will continue to operate as separate, independent companies and continue to compete against one other, consistent
with business as usual. Our antitrust and other policies will remain in full force and effect until we close the transaction.
When we close the transaction, we expect much will stay the same, except as a private company. Cross Country will continue to
operate under our own brand after the closing, and I will continue to serve as President and CEO of Cross Country. We expect employees
of both companies will benefit from shared best practices, with great opportunities for your personal growth.
We will keep you informed as we move
forward. In the meantime, we understand that you may have questions and I encourage you to review the attached FAQ document. Please join
me for a Town Hall meeting later today at 11:30 AM ET where we will share more about what the next several weeks and months will look
like. You will receive an invite to the Town Hall shortly.
Cross
Country Healthcare, Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
I remain incredibly optimistic about
what the future of Cross Country holds as a part of Aya. Thank you for your dedication and unwavering commitment. We look forward to
embarking on this exciting new chapter together!
Respectfully,
John A. Martins
Cross Country President and CEO
If you receive inquiries from media
and other external parties, please direct them to our outside public relations agency, Collected Strategies, at CrossCountry-CS@collectedstrategies.com.
Please direct inquiries from investors and analysts to Josh Vogel at jvogel@crosscountry.com.
Please refrain from discussing the proposed transaction on social media.
Important Information and Where
to Find It
This communication relates to a proposed
transaction between Cross Country Healthcare, Inc. (“Cross Country”) and Aya Healthcare, Inc. (“Aya”)
and certain wholly owned subsidiaries of Aya. In connection with this proposed transaction, Cross Country will file a proxy statement
on Schedule 14A or other documents with the SEC. This communication is not a substitute for any proxy statement or other document that
Cross Country may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF CROSS COUNTRY ARE
URGED TO READ THE PROXY STATEMENT, INCLUDING THE DOCUMENTS INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT, AND OTHER DOCUMENTS THAT
MAY BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
The definitive proxy statement, when available, will be mailed to stockholders of Cross Country as applicable. Investors and security
holders will be able to obtain free copies of these documents, when available, and other documents filed with the SEC by Cross Country
through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Cross Country will be
available free of charge on Cross Country’s internet website at https://ir.crosscountryhealthcare.com/ or by contacting Cross Country’s
primary investor relations contact by email at jvogel@crosscountry.com or by phone at 561-237-8310.
Participants in the Solicitation
Cross
Country Healthcare, Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
Cross Country, Aya,
their respective directors and certain of their respective executive officers may be considered participants in the solicitation of proxies
in connection with the proposed transaction. Information about the directors and executive officers of Cross Country, their ownership
of Cross Country common shares, and Cross Country’s transactions with related persons is set forth in its Annual Report on Form
10-K for the fiscal year ended December 31, 2023, which was filed with the SEC on February 23, 2024 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/1141103/000162828024006454/ccrn-20231231.htm),
in its proxy statement on Schedule 14A for its 2024 Annual Meeting of Stockholders in the sections entitled “Security Ownership
of Certain Beneficial Owners and Management” and “Related Party Transactions”, which was filed with the SEC on April
1, 2024 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/1141103/000114036124016761/ny20018339x1_def14a.htm),
certain of its Quarterly Reports on Form 10-Q and certain of its Current Reports on Form 8-K.
These documents can
be obtained free of charge from the sources indicated above. Additional information regarding the participants in the proxy solicitations
and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement
and other relevant materials to be filed with the SEC when they become available.
No Offer or Solicitation
This communication
is for informational purposes only and is not intended to and shall not constitute an offer to buy or sell or the solicitation of an
offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
jurisdiction.
Cautionary Note Regarding Forward-Looking
Statements
This
communication contains “forward-looking statements” within the Private Securities Litigation Reform Act of 1995. Any statements
contained in this communication that are not statements of historical fact, including statements regarding the proposed transaction,
including the expected timing and closing of the proposed transaction; Cross Country’s ability to consummate the proposed transaction;
the expected benefits of the proposed transaction and other considerations taken into account by the Cross Country Board of Directors
in approving the proposed transaction; the amounts to be received by stockholders and
Cross
Country Healthcare, Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
expectations
for Cross Country prior to and following the closing of the proposed transaction, may be deemed to be forward-looking statements. All
such forward-looking statements are intended to provide management’s current expectations for the future of Cross Country based
on current expectations and assumptions relating to Cross Country’s business, the economy and other future conditions. Forward-looking
statements generally can be identified through the use of words such as “believes,” “anticipates,” “may,”
“should,” “will,” “plans,” “projects,” “expects,” “expectations,”
“estimates,” “forecasts,” “predicts,” “targets,” “prospects,” “strategy,”
“signs,” and other words of similar meaning in connection with the discussion of future performance, plans, actions or events.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances
that are difficult to predict. Such risks and uncertainties include, among others: (i) the timing to consummate the proposed transaction,
(ii) the risk that a condition of closing of the proposed transaction may not be satisfied or that the closing of the proposed transaction
might otherwise not occur, (iii) the risk that a regulatory approval that may be required for the proposed transaction is not obtained
or is obtained subject to conditions that are not anticipated, (iv) the diversion of management time on transaction-related issues, (v)
risks related to disruption of management time from ongoing business operations due to the proposed transaction, (vi) the risk that any
announcements relating to the proposed transaction could have adverse effects on the market price of the common stock of Cross Country,
(vii) the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Cross Country to retain
customers and retain and hire key personnel and maintain relationships with its suppliers and customers, (viii) the occurrence of any
event, change or other circumstance or condition that could give rise to the termination of the Merger Agreement, including in circumstances
requiring Cross Country to pay a termination fee, (ix) the risk that competing offers will be made, (x) unexpected costs, charges or
expenses resulting from the merger, (xi) potential litigation relating to the merger that could be instituted against the parties to
the Merger Agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto, (xii)
worldwide economic or political changes that affect the markets that Cross Country’s businesses serve which could have an effect
on demand for Cross Country’s services and impact Cross Country’s profitability, (xiii) effects from global pandemics, epidemics
or other public health crises, (xiv) changes in marketplace conditions, such as alternative modes of healthcare delivery, reimbursement
and customer needs and (xv) disruptions in the global credit and financial markets, including diminished liquidity and credit availability,
changes in international trade agreements, including tariffs and trade restrictions, cyber-security vulnerabilities, foreign currency
volatility, swings in consumer confidence and spending, costs of providing services, retention of key employees, and outcomes of legal
proceedings, claims and investigations. Accordingly, actual results may differ materially from those contemplated
Cross
Country Healthcare, Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
by
these forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They
are neither statements of historical fact nor guarantees or assurances of future performance. Additional information regarding the factors
that may cause actual results to differ materially from these forward-looking statements is available in Cross Country’s filings
with the SEC, including the risks and uncertainties identified in Part I, Item 1A - Risk Factors of Cross Country’s Annual Report
on Form 10-K for the year ended December 31, 2023 and in Cross Country’s other filings with the SEC. The list of factors is not
intended to be exhaustive.
These
forward-looking statements speak only as of the date of this communication, and Cross Country does not assume any obligation to update
or revise any forward-looking statement made in this communication or that may from time to time be made by or on behalf of Cross Country.
Cross Country Healthcare,
Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
| 1. | Why are Cross Country and Aya
Healthcare combining? |
| · | This
is an exciting next chapter in Cross Country’s nearly 40-year history. |
| · | By
joining forces with Aya, we are advancing our mission to bridge connections between people
and jobs through cutting-edge technology and innovative solutions. |
| · | The
clinical services we provide in clinical and non-clinical settings, including in schools
and homes, as well as our IntellifyTM workforce platform will complement Aya’s
existing capabilities. |
| · | The
combined company will offer solutions across the continuum of care, including travel nursing
and allied health, per diem, permanent staff hiring, interim leadership, locum tenens and
non-clinical professionals in all 50 states. |
| · | Together,
we will be able to help clients reduce the cost of care and deliver high clinical outcomes
for patients. |
| · | Importantly,
we expect the transaction to provide a wider array of opportunities and efficiencies for
our healthcare clinicians and create new opportunities for our employees as part of an industry
leader with a complementary footprint and offering. |
| 2. | What does this announcement mean
for me and my day-to-day responsibilities? |
| · | Today’s
announcement is just the beginning and until the transaction has closed, which we expect
in the first half of 2025, Cross Country remains a separate, independent company. |
| · | During
this interim period, it is business as usual for all of us at Cross Country. We will
continue to compete against Aya and our antitrust policy will remain in effect. |
| · | We
expect no changes to your roles/titles, responsibilities and benefits. |
| · | In
the meantime, both companies will form an integration planning team to determine how best
to bring our companies together. |
| 3. | Will this transaction change our
culture? |
| · | Aya
shares our commitment to the core values that drive how we conduct our business, treat our
employees and serve our customers, and this same focus will guide our actions as we combine
our two companies. |
| · | Just
like us, Aya’s employees are core to its business and it is deeply focused on employee
development with competitive benefits and numerous programs for career development. |
| · | Between
now and closing, there will be no changes in roles or responsibilities. |
| · | As
with any transaction like this one, we anticipate there will be some roles that are no longer
required as we move forward as part of a private company, but we |
Cross Country Healthcare,
Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
anticipate the vast majority
of our team will continue in similar roles once the transaction closes.
| 4. | What will happen to the Cross
Country brand and leadership team? |
| · | Cross
Country will continue to operate under our own brand. |
| · | John
Martin will continue to serve as President and CEO of Cross Country, driving the next phase
of growth and innovation for Cross Country as part of Aya. |
| · | We
expect employees of both companies will benefit from shared best practices, with great opportunities
for personal growth. |
| · | This
transaction is about growth and leveraging the best of both companies. |
| · | However,
as with any transaction of this size, we anticipate there will be some roles that are no
longer required as we move forward as part of a private company. However, we anticipate the
vast majority of our team will continue in similar roles once the transaction closes. |
| · | The
integration planning team will carefully evaluate the necessary resources for the combined
business and will take the utmost care in making those determinations. |
| · | Both
Cross Country and Aya have a shared commitment to timely communications with as much notice
as possible. |
| · | Please
remember that this announcement is the first step in this process and we are operating with
a business as usual mindset. |
| 6. | How does this announcement impact
my compensation or benefits? |
| · | Until
the transaction closes, Cross Country will continue to operate independently and there are
no expected changes to compensation and benefits at this time. |
| 7. | What are the expectations with
regards to interactions between employees of Cross Country and Aya between now and closing?
|
| · | This
is just the beginning of this process and Cross Country will continue to operate independently
until the closing of the transaction. |
| · | During
this interim period, it is business as usual for all of us at Cross Country. We will
continue to compete against Aya and our antitrust policy will remain in effect. |
| · | Between
now and closing, you should not engage with any Aya employees unless a member of the Cross
Country leadership team asks you to do so. |
| · | In
the coming weeks, we will work closely with the Aya team to form an integration planning
team to determine how best to bring our companies together. |
Cross Country Healthcare,
Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
| 8. | If I see a position posted at
Aya I’d like to apply for, what should I do? |
| · | Until
the transaction closes, we will continue to operate as a standalone company. This means there
is no change to your job. |
| · | The
integration planning team will carefully evaluate the necessary resources for the combined
business and will take the utmost care in making those determinations. |
| · | Should
your job be impacted by the transaction, we will assist you through that process and provide
as much support as possible, including finding ways to apply for a different job within Aya. |
| 9. | Will there be any changes to offices
/ locations? |
| · | Following
the closing of the transaction, we expect much will stay the same, we will just be part of
a private company. |
| · | Decisions
related to offices and locations will be made as part of the integration planning process
and we will communicate any changes well in advance. |
| · | As
of now, Aya expects to maintain a significant presence in Boca Raton, Fl. |
| 10. | Does this change our relationship
or contracts with customers, vendors, suppliers or business partners? |
| · | It
is business as usual until the transaction closes and there are no changes to existing contracts
or relationships with customers, vendors, suppliers or business partners. |
| 11. | What happens to the Cross Country
stock I own? |
| · | Upon
closing of the transaction, each Restricted Stock Award will be automatically converted into
$18.61/share in cash, subject to and in accordance with the terms of the Merger Agreement
(which is publicly available). |
| · | If
you hold Performance Share Awards, a portion (not all) of your PSAs will also be converted
into $18.61/share in cash. |
| · | If
you own Cross Country stock, there is no action you need to take right now. |
| · | We
will hold a Special Meeting of Cross Country stockholders to approve the transaction in 2025,
the date of which has not yet been set. |
| · | We
will communicate with all Cross Country stockholders, including employee owners, with more
information about the Special Meeting. |
Cross Country Healthcare,
Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
| 12. | What are the next steps to close
the transaction? |
| · | There
are various required approvals we need to obtain, including from Cross Country stockholders
and select regulatory agencies, in addition to the satisfaction of other customary closing
conditions. |
| · | We
expect to achieve these approvals and close the transaction in the first half of 2025. |
| 13. | Who can I contact if I have more
questions? |
| · | If
you have additional questions, please don’t hesitate to reach out to your HR representative. |
| · | As
always, we will be transparent and communicate important updates, as appropriate. |
| 14. | What do I do if I am contacted
by an outside third party? |
| · | If
you receive inquiries from media and other external parties, please direct them to our outside
public relations agency, Collected Strategies, at CrossCountry-cs@collectedstrategies.com. |
| · | Please
direct inquiries from investors and analysts to Josh Vogel at jvogel@crosscountry.com. |
Important Information and Where
to Find It
This communication relates to a proposed
transaction between Cross Country Healthcare, Inc. (“Cross Country”) and Aya Healthcare, Inc. (“Aya”)
and certain wholly owned subsidiaries of Aya. In connection with this proposed transaction, Cross Country will file a proxy statement
on Schedule 14A or other documents with the SEC. This communication is not a substitute for any proxy statement or other document that
Cross Country may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF CROSS COUNTRY ARE
URGED TO READ THE PROXY STATEMENT, INCLUDING THE DOCUMENTS INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT, AND OTHER DOCUMENTS THAT
MAY BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
The definitive proxy statement, when available, will be mailed to stockholders of Cross Country as applicable. Investors and security
holders will be able to obtain free copies of these documents, when available, and other documents filed with the SEC by Cross Country
through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Cross Country will be
available free of charge on Cross Country’s internet website at https://ir.crosscountryhealthcare.com/ or by
Cross Country Healthcare,
Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
contacting Cross Country’s primary
investor relations contact by email at jvogel@crosscountry.com or by phone at 561-237-8310.
Participants in the Solicitation
Cross Country, Aya,
their respective directors and certain of their respective executive officers may be considered participants in the solicitation of proxies
in connection with the proposed transaction. Information about the directors and executive officers of Cross Country, their ownership
of Cross Country common shares, and Cross Country’s transactions with related persons is set forth in its Annual Report on Form
10-K for the fiscal year ended December 31, 2023, which was filed with the SEC on February 23, 2024 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/1141103/000162828024006454/ccrn-20231231.htm),
in its proxy statement on Schedule 14A for its 2024 Annual Meeting of Stockholders in the sections entitled “Security Ownership
of Certain Beneficial Owners and Management” and “Related Party Transactions”, which was filed with the SEC on April
1, 2024 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/1141103/000114036124016761/ny20018339x1_def14a.htm),
certain of its Quarterly Reports on Form 10-Q and certain of its Current Reports on Form 8-K.
These documents can
be obtained free of charge from the sources indicated above. Additional information regarding the participants in the proxy solicitations
and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement
and other relevant materials to be filed with the SEC when they become available.
No Offer or Solicitation
This communication
is for informational purposes only and is not intended to and shall not constitute an offer to buy or sell or the solicitation of an
offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
jurisdiction.
Cautionary Note Regarding Forward-Looking
Statements
This
communication contains “forward-looking statements” within the Private Securities Litigation Reform Act of 1995. Any statements
contained in this communication that are not
Cross Country Healthcare,
Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
statements
of historical fact, including statements regarding the proposed transaction, including the expected timing and closing of the proposed
transaction; Cross Country’s ability to consummate the proposed transaction; the expected benefits of the proposed transaction
and other considerations taken into account by the Cross Country Board of Directors in approving the proposed transaction; the amounts
to be received by stockholders and expectations for Cross Country prior to and following the closing of the proposed transaction, may
be deemed to be forward-looking statements. All such forward-looking statements are intended to provide management’s current expectations
for the future of Cross Country based on current expectations and assumptions relating to Cross Country’s business, the economy
and other future conditions. Forward-looking statements generally can be identified through the use of words such as “believes,”
“anticipates,” “may,” “should,” “will,” “plans,” “projects,”
“expects,” “expectations,” “estimates,” “forecasts,” “predicts,” “targets,”
“prospects,” “strategy,” “signs,” and other words of similar meaning in connection with the discussion
of future performance, plans, actions or events. Because forward-looking statements relate to the future, they are subject to inherent
risks, uncertainties and changes in circumstances that are difficult to predict. Such risks and uncertainties include, among others:
(i) the timing to consummate the proposed transaction, (ii) the risk that a condition of closing of the proposed transaction may not
be satisfied or that the closing of the proposed transaction might otherwise not occur, (iii) the risk that a regulatory approval that
may be required for the proposed transaction is not obtained or is obtained subject to conditions that are not anticipated, (iv) the
diversion of management time on transaction-related issues, (v) risks related to disruption of management time from ongoing business
operations due to the proposed transaction, (vi) the risk that any announcements relating to the proposed transaction could have adverse
effects on the market price of the common stock of Cross Country, (vii) the risk that the proposed transaction and its announcement could
have an adverse effect on the ability of Cross Country to retain customers and retain and hire key personnel and maintain relationships
with its suppliers and customers, (viii) the occurrence of any event, change or other circumstance or condition that could give rise
to the termination of the Merger Agreement, including in circumstances requiring Cross Country to pay a termination fee, (ix) the risk
that competing offers will be made, (x) unexpected costs, charges or expenses resulting from the merger, (xi) potential litigation relating
to the merger that could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers,
including the effects of any outcomes related thereto, (xii) worldwide economic or political changes that affect the markets that Cross
Country’s businesses serve which could have an effect on demand for Cross Country’s services and impact Cross Country’s
profitability, (xiii) effects from global pandemics, epidemics or other public health crises, (xiv) changes in marketplace conditions,
such as alternative modes of healthcare delivery, reimbursement and customer needs and (xv) disruptions in the global
Cross Country Healthcare,
Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
credit
and financial markets, including diminished liquidity and credit availability, changes in international trade agreements, including tariffs
and trade restrictions, cyber-security vulnerabilities, foreign currency volatility, swings in consumer confidence and spending, costs
of providing services, retention of key employees, and outcomes of legal proceedings, claims and investigations. Accordingly, actual
results may differ materially from those contemplated by these forward-looking statements. Investors, therefore, are cautioned against
relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future
performance. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking
statements is available in Cross Country’s filings with the SEC, including the risks and uncertainties identified in Part I, Item
1A - Risk Factors of Cross Country’s Annual Report on Form 10-K for the year ended December 31, 2023 and in Cross Country’s
other filings with the SEC. The list of factors is not intended to be exhaustive.
These
forward-looking statements speak only as of the date of this communication, and Cross Country does not assume any obligation to update
or revise any forward-looking statement made in this communication or that may from time to time be made by or on behalf of Cross Country.
Cross Country Healthcare,
Inc.
6551 Park of Commerce
Blvd., Boca Raton, FL 33487
(800) 347.2264 | crosscountry.com
Cross Country Health (NASDAQ:CCRN)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Cross Country Health (NASDAQ:CCRN)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
